tirzepatide class action lawsuit Novo Nordisk filed a against Eli Lilly & Co. accusing the manufacturer of weight-loss drug Zepbound of deceptive advertising for allegedly comparing high doses of its drug to low doses of Zepbound Lawsuit [2026] | Gastrointestinal
Pay in 4 interest-free payments of $7.27 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
![tirzepatide class action lawsuit Novo Nordisk filed a against Eli Lilly & Co. accusing the manufacturer of weight-loss drug Zepbound of deceptive advertising for allegedly comparing high doses of its drug to low doses of Zepbound Lawsuit [2026] | Gastrointestinal](https://www.torhoermanlaw.com/wp-content/uploads/2026/02/Zepbound-Lawsuit-Other-Drugs-and-Manufacturers-Named-in-the-GLP-1-Lawsuits-torhoerman-law.jpg)
![tirzepatide class action lawsuit Novo Nordisk filed a against Eli Lilly & Co. accusing the manufacturer of weight-loss drug Zepbound of deceptive advertising for allegedly comparing high doses of its drug to low doses of Zepbound Lawsuit [2026] | Gastrointestinal](https://thehill.com/wp-content/uploads/sites/2/2023/11/654bcfee839151.28440666-e1741301604171.jpeg?w=1280)
![tirzepatide class action lawsuit Novo Nordisk filed a against Eli Lilly & Co. accusing the manufacturer of weight-loss drug Zepbound of deceptive advertising for allegedly comparing high doses of its drug to low doses of Zepbound Lawsuit [2026] | Gastrointestinal](https://images.ctfassets.net/4f3rgqwzdznj/7fHm0MgdcJErTzFJcYqIQM/ad4f6ae27c92918f5ded831f0f121e9f/Tirzepatide_FDA_Approval_Process.png)
![tirzepatide class action lawsuit Novo Nordisk filed a against Eli Lilly & Co. accusing the manufacturer of weight-loss drug Zepbound of deceptive advertising for allegedly comparing high doses of its drug to low doses of Zepbound Lawsuit [2026] | Gastrointestinal](https://www.torhoermanlaw.com/wp-content/uploads/2026/05/Health-Effects-Linked-to-GLP-1-Drugs-Named-in-Lawsuits.jpg)
![tirzepatide class action lawsuit Novo Nordisk filed a against Eli Lilly & Co. accusing the manufacturer of weight-loss drug Zepbound of deceptive advertising for allegedly comparing high doses of its drug to low doses of Zepbound Lawsuit [2026] | Gastrointestinal](https://uptowninjury.com/wp-content/uploads/2024/12/Mounjaro-Lawsuit-Update-2024-Kyle-Newman-Founder-and-Senior-Trial-Lawyer-at-Uptown-Injury-New-Yorks-Mounjaro-Lawsuit-lawyer-In-New-York.webp-1024x576.webp)
![tirzepatide class action lawsuit Novo Nordisk filed a against Eli Lilly & Co. accusing the manufacturer of weight-loss drug Zepbound of deceptive advertising for allegedly comparing high doses of its drug to low doses of Zepbound Lawsuit [2026] | Gastrointestinal](https://images.foxtv.com/static.livenowfox.com/www.livenowfox.com/content/uploads/2026/05/1280/720/gettyimages-2126120470-scaled.jpg?ve=1&tl=1)






















